Tayag, Lorgina .

HRN: 22-32-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2023
AMPICILLIN 1GM (VIAL)
02/16/2023
02/16/2023
IV
2 G
Now Then Q6
PROM
Waiting Final Action 
02/16/2023
CEFUROXIME 500MG (TAB)
02/16/2023
02/23/2023
ORAL
500mg
BID
S/P NSVD With Laceration And Repair;
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: